Patents by Inventor Elizabeth M. Todd

Elizabeth M. Todd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11964001
    Abstract: The present invention provides compositions and method for treating a subject having or suspected of having pulmonary dysfunction resulting from impaired alveolar macrophage (AM) development. The compositions comprise granulocyte-macrophage colony stimulating factor (GM-CSF) in formulations suitable for pulmonary airway administration.
    Type: Grant
    Filed: April 9, 2020
    Date of Patent: April 23, 2024
    Assignee: Washington University
    Inventors: Sharon Celeste Morley, Elizabeth M. Todd
  • Publication number: 20200323959
    Abstract: The present invention provides compositions and method for treating a subject having or suspected of having pulmonary dysfunction resulting from impaired alveolar macrophage (AM) development. The compositions comprise granulocyte-macrophage colony stimulating factor (GM-CSF) in formulations suitable for pulmonary airway administration.
    Type: Application
    Filed: April 9, 2020
    Publication date: October 15, 2020
    Applicant: Washington University
    Inventors: Sharon Celeste Morley, Elizabeth M. Todd